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Host intracellular Signaling events 
and Pro-inflammatory Cytokine 
Production in African 
Trypanosomiasis
Shiby M. Kuriakose†, Rani Singh†‡ and Jude E. Uzonna*
Department of Immunology, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
Pathogens, such as bacteria, viruses, and parasites, possess specific molecules or 
proteins that are recognized by several host innate immune receptors, leading to the 
activation of several intracellular signaling molecules and pathways. The magnitude 
and quality of these events significantly affect the outcome of infection. African try-
panosomes, including Trypanosoma congolense, are capable of manipulating the host 
immune response, including the activity of macrophages, which are the key immune 
cells that contribute to the immunopathogenesis of African trypanosomiasis. Although it 
is known that immune hyperactivation and excessive pro-inflammatory cytokine produc-
tion are the hallmarks of African trypanosomiasis, the mechanisms through which these 
events are triggered are poorly defined. However, it is known that macrophages may 
play a significant role in these processes, because phagocytosis of trypanosomes by 
macrophages initiates intracellular signal transduction cascades that lead to the release 
of pro-inflammatory cytokines and alteration in cell function. This review highlights recent 
progress in our understanding of the innate immune receptors, signaling pathways, and 
transcription factors involved in T. congolense-induced pro-inflammatory cytokine pro-
duction in macrophages. It will reveal the existence of complex signaling events through 
which the parasite modulates the host immune response, thus identifying novel targets 
that could aid in designing strategies to effectively control the disease.
Keywords: African trypanosomiasis, intracellular signaling peptides and proteins, pro-inflammatory cytokines, 
innate immune response, host–parasite interactions
iNTRODUCTiON
African trypanosomes are flagellated protozoan parasites that cause disease in both humans and 
animals. The disease in humans is called human African trypanosomiasis (HAT) or sleeping sickness 
and is considered as a neglected disease along with other parasitic diseases, such as leishmaniasis 
and schistosomiasis (1). Other than malaria and schistosomiasis, HAT is the third significant 
contributor to the global burden of parasitic diseases (1). The disease in humans is mainly caused 
by Trypanosoma (T.) brucei rhodesiense and T. brucei gambiense. Animal African trypanosomiasis 
(AAT), otherwise called Nagana, is caused by T. congolense, T. brucei brucei, and T. vivax. T. con-
golense is the major species that primarily cause animal trypanosomiasis, particularly in domestic 
livestock. The disease is transmitted to the mammalian host by the bite of several species of infected 
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tsetse fly vector belonging to the genus Glossina. The incidence of 
animal trypanosomiasis coincides with the distribution of their 
tsetse fly vectors and according to the 2014 WHO report, tsetse fly 
transmitted trypanosomiasis occurs in 36 sub-Saharan countries 
and covers almost 10 million square kilometers of the African 
continent (2).
African trypanosomiasis is of considerable economic and 
social importance and is one of the most important factors 
restricting economic development in Africa (3). The disease 
threatens the health of about 70 million people and 50 million 
cattle (4). According to the 2014 WHO fact sheet, the estimated 
number of actual cases is 20,000, with an estimated 70 million 
people at risk of developing the disease (2). Due to the continued 
control efforts, the number of cases has dropped for the first time 
in last 50 years (2). However, sporadic cases and small outbreaks 
are reported increasingly in patients in non-endemic countries 
despite the decline in the number of new cases among Africans 
(5). It is estimated that about 50 cases of HAT occur annually out-
side Africa, and 94 cases of HAT were reported in 19 non-disease 
endemic African countries during the period of 2000–2010 (5, 6).
Although animal trypanosomiasis can occur in all domes-
ticated animals, cattle are the main species affected due to the 
feeding preferences of tsetse flies. The disease adversely affects 
livestock production and farming and has a major impact on 
human and economic development. It is estimated that three 
million cattle die annually from the disease, and the estimated 
economic loss in cattle production is about 4 billion US dollars 
per year (7). Despite the fact that the disease kills or disables 
hundreds of thousands of people and animals in endemic areas, 
the treatment for the disease is not satisfactory. Currently, there 
are no vaccines available to prevent the disease in both humans 
and animals, and the current treatment methods have several 
limitations, and the development of drug resistance is a growing 
problem.
iMMUNiTY TO AFRiCAN 
TRYPANOSOMiASiS
innate immunity
Studies have shown that various animal species respond differently 
to infections with various species of African trypanosomes. For 
example, the West African cattle breeds, such as the N’Dama, are 
naturally resistant (trypanotolerant) to African trypanosomiasis, 
whereas the zebu-type cattle breeds, such as Boran, are com-
paratively susceptible (trypanosusceptible). Similarly, different 
mouse strains show varying resistance to infections with African 
trypanosomes. The relatively resistant C57BL/6 represents the 
trypanotolerant phenotype, whereas highly susceptible Balb/c 
mice represent trypanosusceptible phenotype. The differential 
resistance and susceptibility in animals have been associated 
with difference in genetic factors and immune responses, includ-
ing innate immunity. Both humoral (serum-associated) and 
cellular factors contribute to the innate immunity to African 
trypanosomes.
It has long been known that humans and some primates are 
naturally resistant to infections with certain species of African 
trypanosomes like T. brucei brucei, T. congolense, and T. vivax (8). 
This resistance is due to the presence of trypanosome lytic factors 
(TLF) that are present in the serum (9, 10). The key components 
of TLFs are apolipoprotein L-1 (APOL-1) and hepatoglobin-
related protein (Hpr) (9). Evidences suggest that APOL-1 kills 
trypanosomes through the binding of its N-terminal domain into 
the parasite lysosomal membrane, leading to the generation of 
ionic pores (11). APOL-1 exists in two forms, the high-density 
lipoprotein-bound TLF, termed as TLF1, and a large lipid poor 
IgM/APOL-1 complex, termed as TLF2 (12, 13). These two 
complexes enter the parasites through different uptake modes, 
but their mechanism of cytotoxicity is same (14).
Apart from soluble serum factors, the innate immune cells 
also play a crucial role in the immunopathogenesis of African 
trypanosomiasis. Macrophages are perhaps one of the most 
important innate cells involved in this process. Studies show that 
the activation of macrophages in infected animals may have a 
dual role (protection and disease exacerbation) in African trypa-
nosomiasis. Activated macrophages release reactive nitrogen and 
oxygen species that have toxic and cytostatic effects on the para-
sites (15, 16). In addition, macrophages also actively participate 
in the phagocytosis and clearance of opsonized parasites (17). 
However, excessive macrophage activation leads to the release 
of large amount of pro-inflammatory cytokines and induces 
immunopathology.
The activation of macrophages in African trypanosomiasis is 
initiated by the receptor-mediated interaction with parasite mol-
ecules that could result in phagocytosis. In particular, the interac-
tion between the GPI membrane that anchors the parasite VSG 
molecule and the pattern recognition receptors (PRRs) results in 
macrophage activation, triggering an inflammatory response. In 
T. brucei infection, the activation of the innate immune system 
is mediated through the adaptor protein MyD88 (18). Although 
the parasite molecule that binds to macrophages in T. congolense 
infection has not been identified yet, studies from our lab 
have shown that immune activation is initiated by the binding 
of the parasite to the toll-like receptor 2 (TLR2) expressed on 
macrophages. This binding leads to the activation of various 
intracellular signaling molecules and pathways associated with 
inflammation. Thus, we showed that T. congolense-induced acti-
vation of mitogen-activated protein kinases (MAPKs) and signal 
transducer and activator of transcription (STAT) proteins in 
macrophages results in the production of various pro-inflamma-
tory cytokines, including IL-6, IL-12, and TNF, and collectively 
activates the adaptive immune response. T. congolense-induced 
innate immune receptor activation and signaling events are 
explained later in this review.
Adaptive immunity
Effective immunity to any microbe requires efficient recognition 
of antigens derived from the microbe by the host immune system, 
which is followed by the generation of effector T and B cells, lead-
ing to the production of cytokines and antibodies, respectively. 
Due to their extracellular life style, effective immunity against 
African trypanosomes depends on optimal antibody production 
by B cells. However, this is severely hindered by the inherent abil-
ity of the parasites to undergo antigenic variation.
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The variant surface glycoprotein (VSG) is a dense, protective 
surface coat that covers the plasma membrane of African trypano-
somes. Although VSG induces strong B cell (antibody) response 
and anti-VSG variant-specific antibodies are effective in clearing 
clones expressing that specific VSG, the ability of the parasite to 
switch from expressing one VSG to another on its surface helps 
it to effectively evade the host immune system by being one step 
ahead of the host’s immune response (19). The constant cycling 
of parasites (expression of new VSGs) and antibody responses 
throughout the infection result in undulating parasitemia and 
chronic infections in African trypanosomiasis.
Since African trypanosomes are extracellular parasites, 
antibodies are required for protection. In T. congolense-infected 
animals, the production of antibodies against the parasite VSG 
occurs early after infection. Previous studies have shown that the 
clearance of parasites in trypanosome-infected mice is correlated 
with the serum levels of parasite-specific antibodies, particularly 
IgG2a and IgG3, but not with IgM antibodies (20). It is also clear 
from several studies that resistant mouse strains mount earlier and 
higher anti-VSG antibody response than the relatively susceptible 
mouse strains (20). Although anti-VSG antibodies are necessary, 
they are not sufficient for controlling T. congolense infection in the 
highly susceptible Balb/c mice. Interestingly, enhanced resistance 
to T. congolense-infected mice is correlated with serum levels of 
antibodies against common trypanosomal antigens (20).
Dysregulation of cytokine network is a hallmark of African 
trypanosomiasis and excessive production of inflammatory 
cytokines, and the release of inflammatory mediators has been 
proposed as a major cause of death in infected animals (20–22). 
The effect of cytokines in the course of trypanosomiasis is 
dependent on timing, microenvironment, quality, and quantity 
being produced. For example, type I cytokines have been 
shown to confer resistance to African trypanosomes by limit-
ing parasite growth during the early stage of infection (20, 21). 
However, sustained type I cytokine response may be harmful 
and promote disease progression (23, 24). In line with this, it 
has been shown that anti-IFN-γ treatment resulted in very low 
parasitemia, control of several waves of parasitemia, and over 
fourfold increase in survival period in the highly susceptible 
BALB/c mice (25). However, infection of IFN-γ-knockout mice 
showed that IFN-γ is required for the survival of the relatively 
resistant mice to T. congolense or T. brucei infections. Thus, 
infected, relatively resistant C57BL/6 mice failed to control their 
first wave of parasitemia and succumbed acutely to the infection 
(21, 26). Also, the induction of IFN-γ production in CD8+ T cells 
by trypanosomal-activating molecule has been shown to lead to 
susceptibility (27). IL-10 is another cytokine that has been shown 
to be critical for trypanotolerance. Deficiency of IL-10 resulted 
in a striking reduction in the survival time of T. congolense- and 
T. brucei-infected mice, and this was associated with increased 
levels of serum pro-inflammatory cytokines like IFN-γ, TNF, and 
NO (28, 29). This has led to the conclusion that IL-10 is critically 
important for dampening excessive inflammatory state caused by 
overproduction of pro-inflammatory cytokines.
BALB/c mice are highly susceptible to experimental T. congo-
lense and T. brucei infections, whereas C57BL/6 mice are relatively 
resistant. Death in the highly susceptible BALB/c mice is associated 
with systemic inflammatory response syndrome and shock-like 
state due, in part, to excessive production of pro-inflammatory 
cytokines and immune hyperactivation (22, 30). Thus, death of 
the susceptible animals is due to disease-associated complications 
and not primarily related to excessive parasite load itself. A recent 
report shows that while T. congolense-infected wild-type (WT) 
and CD4−/− (CD4+ T cell-deficient) BALB/c mice have similar 
parasitemia and survival time, partial depletion of CD4+ T cells 
in WT mice leads to lower parasitemia and longer survival than 
infected normal WT mice (28). This partial depletion of CD4+ T 
cells also resulted in reduced IFN-γ production without affecting 
IL-10 and parasite-specific IgG antibody production (28). This 
observation further supports the notion that the early mortality 
of the infected BALB/c mice is due to the excessive IFN-γ pro-
duction, which in turn exerts pathology by causing macrophage 
hyperactivation and excessive pro-inflammatory cytokine 
production. Thus, an optimal/balanced cytokine response is 
needed at the initial stage of the infection for parasite clearance, 
and IFN-γ-producing CD4+ T cells play an important role in the 
immunopathogenesis of African trypanosomiasis.
It has been known for long that many indigenous African 
mammals can harbor natural trypanosome infections without 
developing severe disease symptoms (31). In particular, while 
the indigenous West African N’Dama cattle are relatively 
 resistant, the exotic zebu breeds are highly susceptible to African 
trypanosomiasis (32). The extreme susceptibility of exotic cattle 
breeds imported to sub-Saharan Africa may be related to exces-
sive (rather than impaired) immune response and/or activation. 
Likewise, in HAT, death is usually due to the nature of the host 
immune reaction, as inflammatory cytokines play an important 
role in the development of trypanosomiasis-associated disease 
complications (33, 34).
Regulatory T cells (Tregs) have been shown to play an 
important role in the pathogenesis of several infectious diseases 
(35–37). However, their role in the pathogenesis of African trypa-
nosomiasis is controversial. For example, one report suggests 
that Tregs play a crucial role in the enhanced resistance of mice 
to T. congolense infections (38). In this study, it was shown that 
CD4+CD25+Foxp3+ (Tregs) limit excessive IFN-γ production by 
CD4+ and CD8+ T cells and thereby downregulate macrophage 
activation and subsequent production of pro-inflammatory 
cytokines (38). However, overwhelming evidence from several 
studies suggest that Tregs may contribute to susceptibility to 
infection with African trypanosomes (39, 40). For example, Wei 
and Tabel showed that depletion of CD4+CD25+Foxp3+ T cells by 
anti-CD25 mAb leads to complete control of infection in highly 
susceptible BALB/c mice (39). In line with this, studies from our 
lab have shown that Tregs contribute to enhanced susceptibility 
to experimental T. congolense infection in mice (40). Following 
T. congolense infection, Tregs contributed to enhanced disease in 
both relatively resistant C57BL/6 and highly susceptible Balb/c 
mice. Depletion of Tregs by using anti-CD25 mAb showed that 
Tregs negatively affect efficient parasite control, whereas adoptive 
transfer of highly enriched CD4+ CD25+ Foxp3+ T cells resulted 
in increased peak parasitemia and production of disease exacer-
bating inflammatory cytokines like IFN-γ and IL-6 during early 
infection in the resistant C57BL/6 mice (40, 41).
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ROLe OF MACROPHAGeS iN AFRiCAN 
TRYPANOSOMiASiS
Macrophages play a crucial role in the control of many proto-
zoan parasitic infections, including African trypanosomiasis. 
Intact monocytic cell system is important for the initiation 
and maintenance of anti-trypanosome responses, because the 
mononuclear phagocytic system is crucial in the phagocytosis of 
opsonized trypanosomes (13), which is the major mechanism for 
the removal of trypanosomes from the blood stream. During the 
course of trypanosome infection, the numbers of macrophages 
are greatly increased in many organs, including the liver, spleen, 
and lymph nodes, and these cells display morphological and 
functional features of activation (42, 43). Because phagocytosis of 
trypanosomes by macrophages (mainly Kupffer cells) leads to the 
production of pro-inflammatory cytokines (22), macrophages 
also play a critical role in mediating immunopathology in infected 
mice. The activation of macrophages during trypanosome infec-
tion is due, in part, to their exposure to parasite components and 
host-derived IFN-γ produced in response to parasite antigens by 
T cells (44). The parasite antigens include invariant membrane, 
cytoplasmic, nuclear antigens, and the VSG. Although the exact 
mechanism of attachment and phagocytosis of trypanosomes 
by  macrophages is not fully understood, optimal phagocytosis 
has been shown to occur in the presence of variant-specific 
 antibodies (45, 46).
Several studies have investigated the activation of macrophages 
following infection with different species of African trypanosomes. 
In experimental T. brucei infection, a large percentage of splenic 
macrophages exhibit membrane and functional characteristics 
associated with immune activation, release large amounts of 
IL-12, TNF, and nitric oxide, and contribute to the modulation 
of host immunity and resistance (47). In T. congolense infection, 
the complement and antibody-mediated phagocytosis by splenic 
and liver (Kupffer cells) macrophages is the major mechanism by 
which trypanosomes are cleared from an infected host (17, 48). 
The uptake of antibody-coated (including IgM and IgG) parasites 
by macrophages results in their activation and production of nitric 
oxide and pro-inflammatory cytokines (16). In addition, activated 
macrophages present trypanosomal antigens to CD4+ T cells in 
an MHC class II-dependent manner resulting in the production 
of IFN-γ (28), further enhancing macrophage activation and pro-
inflammatory cytokines production. Furthermore, the massive 
phagocytosis of parasites by splenic and hepatic macrophages 
at the peak parasitemia further leads to their hyperactivation 
and increased production of nitric oxide, monokines, and pro-
inflammatory cytokines. This systemic cytokine overproduction 
leads to systemic inflammatory response like syndrome, which 
contributes to the death of trypanosome-infected mice (28). 
Indeed, our group previously showed that following T. congo-
lense infection, both splenic and hepatic macrophages produce 
copious amounts of pro-inflammatory cytokines that in turn 
contribute to disease and mortality (49). Treatment of infected 
mice with berenil (a trypanocide) significantly downregulated 
pro-inflammatory cytokine production and led to survival from 
an otherwise lethal infection in the highly susceptible BALB/c 
mice (49).
Direct evidence for the involvement of macrophages in the 
production of pro-inflammatory cytokines, following interac-
tion with T. congolense, has been demonstrated in vitro. Kaushik 
et al. found that bone marrow-derived macrophages (BMDMs) 
produce an array of cytokines, including IL-6, TNF, and IL-12, 
upon stimulation with T. congolense and T. brucei whole cell lysate 
(50). Interestingly, they also showed that BMDMs from the highly 
susceptible BALB/c mice produced significantly more of these 
cytokines than those from the relatively resistant C57BL/6 mice 
(50). This is consistent with the notion that acute death observed 
in the infected BALB/c mice might be due to unregulated immune 
activation and excessive pro-inflammatory cytokine produc-
tion. We have confirmed that the stimulation of BMDMs with 
T. congolense induces IL-6, IL-12, and TNF production, and this 
is dependent on intracellular signals resulting from activation 
of MAPKs and STAT proteins (STAT1 and STAT3). We further 
delineated the innate receptor involved in the recognition of the 
parasite constituent(s) and showed the critical involvement of the 
adaptor molecule, MyD88, in these processes.
M1 versus M2 Macrophages
Macrophage activation is a term used to describe macrophages 
that have been primed or stimulated to show enhanced effector 
activities. Depending on the nature of activating stimuli and the 
eventual phenotype displayed, activated macrophages are clas-
sified into two major groups: classically activated macrophages 
or M1 type and alternatively activated macrophages or M2 type. 
The classical activation denotes effector macrophages that are 
produced during cell-mediated immune responses. Classically 
activated macrophages secreted high levels of pro-inflammatory 
cytokines and mediators and exhibit enhanced microbicidal and 
tumoricidal capacity. IFN-γ, produced by innate or adaptive 
immune cells, is the major molecule involved in the classical 
activation of macrophages (51). In contrast, Th2 cytokines, such 
as IL-4 and IL-13, are the key drivers of alternative macrophage 
activation (52). Alternatively activated macrophages are poor 
at antigen presentation to T cells, are less efficient at producing 
toxic oxygen and nitrogen radicals, and do not effectively kill 
intracellular pathogens (53). However, they are important in the 
clearance of helminth and nematode infections (54, 55).
Several studies have shown that the cytokine environment dur-
ing African trypanosomiasis is key at influencing the activation of 
macrophages, resulting in the development of M1 and M2 subsets 
that are regulated antagonistically (56). Classically activated 
macrophages (M1) develop during the early stage of infection in 
the presence of type I cytokine environment (IFN-γ and TNF). 
In contrast, alternatively activated macrophages (M2) develop 
during the late stage of infection when a type II cytokine environ-
ment (IL-4, IL-10, TGF-β, etc.) predominates (56). As in other 
infections, M1 macrophages from mice infected with African 
trypanosomes have been shown to possess pro-inflammatory 
properties and produce nitric oxide, reactive oxygen species, and 
TNF, whereas M2 macrophages have anti-inflammatory proper-
ties due to increased arginase activity and IL-10 production (56). 
The development of M1 macrophages during the early stage of 
the disease appears to be responsible for the early release of pro-
inflammatory mediators associated with type I immune response, 
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and this could contribute to the control of initial parasitemic 
waves. Also, the activation of M1 macrophages could result in 
collateral damage to tissues as seen in the liver and spleen (57). 
A switch from M1 to M2 macrophages occurs after the clearance 
of initial waves of parasitemia in the relatively resistant mice 
(13). The resultant secretion of anti-inflammatory mediators by 
these M2 macrophages is thought to actively participate in tissue 
 healing (56, 57).
iNNATe iMMUNe ReCePTORS AND 
ADAPTOR PROTeiNS iN AFRiCAN 
TRYPANOSOMiASiS
The germline-encoded innate receptor families, also known as 
PRRs, are critical for initiating innate immune responses in the 
host. They include nucleotide-binding oligomerization domain 
(NOD)-like receptors (NLRs), RIG-1-like receptors (RLRs), 
membrane-bound C-type lectin receptors (CLRs), and trans-
membrane toll-like receptors (TLRs). TLRs are the most widely 
studied PRRs and play an important role in the recognition of 
molecular signatures on microbes resulting in the initiation of 
inflammatory response (58). They are the first group of PRRs 
identified and have been shown to recognize a wide range of 
pathogen-associated molecular patterns (PAMPs) (59, 60). By 
inducing distinct gene expression patterns, stimulation of differ-
ent TLRs leads to the activation of innate immunity, which in turn 
instructs the development of antigen-specific acquired immunity 
(61). Ten human and twelve mice functional TLRs have been 
identified till date, and each TLR detects distinct PAMPs derived 
from bacteria, viruses, fungi, and parasites (62, 63).
Toll-like receptor-mediated intracellular signaling events are 
initiated by the binding of different TLRs with their correspond-
ing ligands, resulting in the recruitment of a number of adaptor 
proteins. Myeloid differentiation primary response protein 88 
(MyD88) is the major adaptor protein that is involved in almost 
all TLR signaling pathways. The other adaptor proteins are 
TIR-domain-containing adaptor protein (TIRAP), TIR-domain-
containing adaptor-inducing IFN-β (TRIF), and TRIF-related 
adaptor molecule (TRAM) (58, 64). The activation of these 
adaptor molecules, following ligation of TLRs with their specific 
ligands, leads to the activation of various intracellular signaling 
molecules (including MAPKs and STATs) and transcription 
factors, such as nuclear factor kappa B (NFκB) and activating 
protein-1 (AP-1), and a resultant initiation of specific immune 
responses. Mice with genetic ablation of MyD88 are highly 
susceptible to T. cruzi and T. brucei infections due, in part, to 
impaired IL-12 and IFN-γ production (18, 65). In these experi-
mental models, it was proposed that signaling through MyD88 
in innate immune cells has a protective role by activating Th1 
response (18, 65). In contrast, in some experimental models, 
decreased pro-inflammatory responses resulting from the lack of 
MyD88 signaling is beneficial to the host (66). Similarly, the GPI 
anchor from T. cruzi trypomastogotes activates phosphorylation 
of ERK, p38, and IκB in mouse peritoneal macrophages (67), 
and mice deficient in the adaptor protein MyD88 signaling are 
highly susceptible to T. cruzi infection due, in part, to impaired 
pro-inflammatory cytokine production, suggesting that MyD88 
is critical for the activation of MAPKs and NFκB by T. cruzi (65). 
Recently, we showed that deficiency of MyD88 results in inhibi-
tion of T. congolense-induced p38 and STAT1 phosphorylation 
and a concomitant downregulation of IL-6 and IL-12 by mac-
rophages. These findings indicate that this adaptor molecule plays 
an important role in T. congolense-induced pro-inflammatory 
cytokine production in macrophages. They further suggest the 
involvement of TLR-mediated recognition and signaling in 
T. congolense-induced pro-inflammatory cytokine production in 
macrophages.
Although TLRs have been shown to play an important role 
in the innate immune responses to several parasitic infections 
(18, 68–71), their role in immunity to African trypanosomiasis is 
largely unknown. However, the findings that synergistic recogni-
tion of T. cruzi DNA by TLR9 and glycosylphosphatidylinositol 
(GPI) by TLR2 cooperatively lead to the induction of pro-
inflammatory cytokine production in macrophages (72) and 
suggest that TLRs may play an important role in the recognition 
of African trypanosomes, which are related to T. cruzi. Indeed, a 
recent report showed that, in T. brucei infections, TLR2-mediated 
signaling contributes to intra-cerebral control of parasite load in 
the brain (73).
No report has investigated the innate receptor(s) through 
which the innate immune system detects and responds to 
T.  congolense infection. Given that MAPKs, STATs, and NFκB 
pathways are activated, following stimulation of macrophages 
and is dependent on MyD88 signaling, we speculated that TLR(s) 
is/are involved in T. congolense recognition by macrophages. We 
found that the deficiency of either TLR4 or TLR9 does not affect 
intracellular signaling events and pro-inflammatory cytokine 
production in macrophages in response to T. congolense stimula-
tion. In contrast, T. congolense-induced MAPK and STAT phos-
phorylation was significantly downregulated in TLR2-deficient 
macrophages compared to the WT cells, and this was associated 
with a concomitant reduction in IL-6 and IL-12 production. 
This indicates that T. congolense-induced activation of important 
signaling pathways leading to optimal immune response is medi-
ated through TLR2 and may have an important role in regulat-
ing the outcome of the disease. Indeed, T. congolense-infected, 
TLR2-deficient mice on the usually relatively resistant C57BL/6 
background developed uncontrolled parasitemia and died within 
10 days of infection in contrast to their WT counterpart mice that 
controlled several waves of parasitemia and survived for more 
than 100  days. Altogether, these observations show that TLR2 
plays a critical role in T. congolense recognition by macrophages 
and resistance to the parasite. However, it remains to be deter-
mined what parasite moiety is recognized by TLR, although the 
GPI, which anchors VSG to the membrane, is a prime candidate.
iNTRACeLLULAR SiGNALiNG PATHwAYS 
iN AFRiCAN TRYPANOSOMiASiS
The major signaling pathways that are known to induce 
cytokine production in immune cells include MAPK pathway, 
JAK–STAT pathway, and NFκB pathway. MAPKs are a group of 
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highly conserved serine/threonine protein kinases that medi-
ate intracellular signaling events necessary for carrying out a 
variety of fundamental cellular processes, such as proliferation, 
differentiation, motility, stress response, apoptosis, and survival. 
Three major families of MAPKs are recognized including, extra-
cellular signal-regulated kinases (ERK), p38 MAPKs, and c-Jun 
N-terminal kinase/stress-activated protein kinases (JNK-SAPKs) 
(74, 75). STATs were first described by Darnell et al. (76) as tran-
scription factors induced by ligands in IFN-treated cells. Later, 
several other groups showed the critical role of STATs in signal 
transduction pathways by cytokines and growth factors (77). All 
STATs have seven well-defined domains, including an N-terminal 
conserved domain, dimerization domain, SH2 domain, and a 
C-terminal transactivation domain. The amino-terminal region 
prevents dimerization of STATs in their inactive state (78), and 
the SH2 domain is critical for the recruitment of STATs to acti-
vate receptor complexes and also for the interaction with Janus 
(JAK) and Src kinases. This region is the most conserved domain 
among STATs and plays an important role in STAT signaling by 
facilitating homodimerization and heterodimerization, which are 
crucial for nuclear localization and DNA-binding activities (79). 
The activation of MAPKs and STATs is important in regulating 
pro-inflammatory cytokine production in immune cells (80). 
Their activation initiates a cascade of intracellular signaling 
events culminating in the expression of various pro-inflammatory 
genes. Thus, MAPK and STAT family members coordinate and 
propagate multiple inflammatory immune responses (81, 82).
Nuclear factor kappa B is a family of transcription factors that 
play important roles in inflammation, immunity, cell prolifera-
tion, differentiation, and survival. In the inactive state, NFκB is 
complexed with the inhibitory protein IκBα. IκB kinase complex 
is activated by inducing stimuli, leading to the phosphorylation, 
ubiquitination, and degradation of IκB proteins. The degradation 
of IκB proteins releases NFκB dimers resulting in their transloca-
tion to nucleus, where they bind to specific DNA sequences and 
promote transcription of target genes. NFκB family is composed 
of five members in mammals, such as RelA/p65, RelB, c-Rel, p50, 
and p52. All the members are characterized by the presence of 
Rel homology domain (RHD), which is essential for dimerization 
and binding to cognate DNA elements (83).
Although infection with African trypanosomes leads to pro-
found production of pro-inflammatory cytokines, the intracellular 
signaling pathways leading to the production of these cytokines 
are poorly studied. There are sporadic and inconsistent reports 
on the role of MAPK and STAT family proteins in trypanosome-
induced pro-inflammatory cytokine production. Soluble VSG 
of T. brucei rhodesiense has been shown to initiate a cascade of 
ERK, p38, JNK MAPK, and NFκB pathways, eventually leading to 
the expression of various pro-inflammatory genes, such as TNF, 
IL-12, IL-6, and iNOS (84). Consistent with this, several proto-
zoan infections, other than African trypanosomes, have also been 
shown to induce the phosphorylation of various MAPKs, leading 
to enhanced cytokine production. One study shows that ERK and 
p38 phosphorylation was triggered by T. cruzi (a close relative 
of African trypanosomes) GPI anchor, leading to the activation 
of NFκB and culminating in the activation of pro-inflammatory 
genes (67). Another report shows that the T. cruzi induces STAT1 
phosphorylation, both at mRNA and protein levels, and this is 
associated with increased binding of STAT1 homodimers to 
gamma-activated site (GAS) elements, leading to NO produc-
tion (85). In addition, another report showed that infection with 
Toxoplasma gondii leads to MAPK and STAT3 phosphorylation 
and subsequent production of inflammatory cytokines (86, 87). 
These studies suggest that MAPK and STAT family proteins 
may be involved in the induction of pro-inflammatory cytokine 
production by African trypanosomes.
Recent studies from our lab have provided strong evidence 
showing that MAPK and STAT proteins play a critical role in 
T.  congolense-induced pro-inflammatory cytokine production 
in macrophages. Stimulation of immortalized macrophages and 
primary BMDMs with whole cell lysate of T. congolense leads to 
time-dependent phosphorylation of ERK, p38, JNK, STAT1, and 
STAT3 proteins, which was associated with a concomitant pro-
duction of pro-inflammatory cytokines in vivo and in vitro. We 
confirmed the involvement of these pathways in T. congolense-
induced pro-inflammatory cytokine production by showing that 
pretreatment of the cells with specific inhibitors of ERK (U0126), 
p38 (SB203580), JNK (SP600125), STAT1 (Fludarabine), and 
STAT3 (S31-201) cause a significant downregulation of IL-6 and 
IL-12 production in response to trypanosome stimulation1.
Given that the heterodimer consisting of p65 and p50 NFκB 
is critically important in the transcription of pro-inflammatory 
genes, we also assessed whether this key transcription factor is 
involved in T. congolense-induced pro-inflammatory cytokine 
production in macrophages. We found a time-dependent 
increase in the phosphorylation of NFκB p65 upon stimulation 
with T. congolense in macrophages, which corresponded with 
the production of IL-6 and IL-12. Collectively, our results show 
that the stimulation of macrophages with T. congolense extracts 
initiates intracellular signaling cascades, involving phosphoryla-
tion of MAPKs and STATs, leading to the eventual activation of 
the master transcription factor, of NFκB. The overall result is the 
transcription of pro-inflammatory genes and subsequent release 
of pro-inflammatory cytokines. However, it remains to be deter-
mined which innate receptor and adaptor molecules are involved 
in initiating these intracellular signaling events.
TRYPANOSOMe-iNDUCeD SiGNALiNG iN 
ReLATiveLY ReSiSTANT veRSUS HiGHLY 
SUSCePTiBLe MURiNe MACROPHAGeS
Although macrophages are critical for clearing parasites in the 
blood following infection with African trypanosomes, their clas-
sical activation and production of pro-inflammatory cytokines 
(IL-6, IL-12, and TNF), nitric oxide, and increased expression of 
MHC class II and co-stimulatory molecules (15, 44, 88, 89) have 
also been shown to contribute to disease pathogenesis and sever-
ity. The degree of this activation and effector function of mac-
rophages has some relationship to the degree of susceptibility of 
1 Kuriakose et al. Trypanosoma congolense induced pro-inflammatory cytokine 
production is by the activation of TLR signaling system through MAPK and STAT 
proteins (submitted).
FiGURe 1 | Signaling pathways involved in Trypanosoma congolense-
induced pro-inflammatory cytokine production in macrophages. The 
recognition of T. congolense by macrophages through toll-like receptor 2 
(TLR2) results in the recruitment of the adaptor protein MyD88 and 
subsequent activation of several intracellular signaling molecules, including 
MAPKs and STATs. Activation of these molecules in turn leads to the 
activation of the transcription factor NFkB, which results in the production of 
IL-6, IL-12, TNF, and nitric oxide (NO). Stimulation of macrophages with 
T. congolense in the presence of IFN-γ produced by CD4+ T cells and other 
immune cells further enhances the activation of these pathways, leading to 
increased proinflammatory cytokine and nitric oxide production.
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different inbred mouse strains to experimental trypanosomiasis. 
Indeed, we previously reported that several cytokine genes are dif-
ferentially regulated in trypanosome-infected macrophages from 
the highly susceptible BALB/c and relatively resistant C57BL/6 
mice (50). IFN-γ-primed primary BMDMs from BALB/c mice, 
when infected with T. brucei or T. congolense whole cell lysate, 
produced significantly higher IL-6 than cells from C57BL/6 mice. 
Similarly, although PBMCs from both highly susceptible Boran 
and relatively resistant N’Dama cattle infected with T. congolense 
showed increased levels of IL-6 mRNA, this rise occurred earlier 
and lasted longer in the Boran than in the N’Dama cattle (90). This 
suggested the possibility of using IL-6 as a predictive marker of 
disease severity in bovine trypanosomiasis. Recent findings from 
our lab suggest the involvement of ERK, JAK–STAT3 pathways in 
T. congolense-induced release of IL-6 by macrophages from both 
BALB/c and C57BL/6 mice.
In contrast to IL-6, macrophages from BALB/c mice produced 
relatively lower TNF and IL-12 than those from C57BL/6 mice 
following trypanosome stimulation. Similar observations have 
been made in monocytes from the relatively resistant and highly 
susceptible cattle breeds (91). TNF is one of the most crucial pro-
inflammatory cytokines that confer immunity against African 
trypanosomiasis. Magez and colleagues (92) found that the 
inhibition of trypanosomiasis-associated pathology in C57BL/6 
and BALB/c mice is correlated with the shedding of soluble p75 
TNF-receptor during peak parasitemia stages. Indeed, infection-
associated pathologies were strongly reduced in both T. brucei 
brucei-infected TNF−/− and TNF-R2−/− mice (92). Because TNF 
signals through both TNF-R1 (55 kDa) and TNF-R2 (75 kDa), 
it has been suggested that TNF-R2 signaling in trypanosomiasis 
mediates infection-associated pathology, whereas TNF-R1 sign-
aling has little or no impact on the infection outcome (92).
In addition to the production of pro-inflammatory cytokines, 
macrophages also produce nitric oxide, which plays a critical role 
in resistance against African trypanosomes via its cytostatic and 
cytotoxic effects (93–95). This is not surprising, given that the 
intracellular signaling pathways that result in the production 
of pro-inflammatory cytokines also lead to the activation of 
the iNOS gene and subsequent production of nitric oxide (96). 
Recently, we showed that in an IFN-γ-enriched environment, 
T. congolense-treated immortalized macrophages and BMDMs 
from the relatively resistant and highly susceptible mice show 
differential phosphorylation of MAPKs and STATs, suggesting 
that African trypanosomes induce differential signaling events 
in macrophages from different strains of mice in  vitro (96). In 
addition to differential MAPK and STAT phosphorylation, T. 
congolense induces significantly higher levels of NO produc-
tion in IFN-γ-primed immortalized macrophages and BMDMs 
the relatively resistant than from highly susceptible mice (96). 
Interestingly, we found that nitric oxide production in mac-
rophages occurred via the activation of MAPK (including p38, 
Erk1/2, and JNK), and this was significantly inhibited by specific 
MAPK inhibitors in BALB/c but not in C57BL/6 cells (96). In 
addition, T. congolense and IFN-γ-induced NO production was 
dependent on STAT1 phosphorylation and was totally suppressed 
by fludarabine (a specific STAT1 inhibitor). We further showed that 
T. congolense-induced differential iNOS transcriptional promoter 
activation in IFN-γ-primed cells is dependent on the activation of 
both GAS1 and GAS2 transcription factors in BALB/c but only on 
GAS1 in C57BL/6 cells (96). Collectively, these observations sug-
gest coordinated, but differentially regulated, signaling pathways 
that lead to NO production in macrophages from the susceptible 
and relatively resistant mice following their interaction with T. 
congolense.
CONCLUDiNG ReMARKS
It is clear from the experimental animal studies that susceptibility 
to African trypanosomiasis is related to immune hyperactiva-
tion, leading to the production of pathogenic pro-inflammatory 
cytokines. However, little is known about the intracellular sign-
aling events and pathways involved in the production of these 
pro-inflammatory cytokines. Understanding these events could 
reveal novel and unexpected aspects of the parasite pathobiology 
that could provide new concepts for understanding host–para-
site interactions, disease pathogenesis, and the major cause of 
susceptibility to the disease. Our recent studies clearly show the 
involvement of TLR2–MyD88-dependent pathway, leading to 
activation of MAPKs, STATs, and NFκB in T. congolense-induced 
pro-inflammatory cytokine production and resistance to the 
infection (Figure 1). The involvement of MAPKs and STATs in 
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T.  congolense-induced cytokine production suggests that target-
ing these pathways offer novel strategies for managing the disease 
in animals infected with African trypanosomes. Indeed, we 
have found that the beneficial effects of berenil (a trypanocide), 
may in addition to its trypanocidal effects, involve its ability to 
downregulate pro-inflammatory cytokine production via inhib-
iting intracellular signaling events, including p38, JNK MAPK, 
STAT1, and STAT3 phosphorylation (49, 97). Thus, targeting 
these pathways may be beneficial for treating disease process 
in animals infected with African trypanosomes. Although we 
have made an attempt to delineate some signaling mechanisms 
in macrophages, following their interaction with trypanosomal 
molecules, there are still important questions that remain 
unanswered and require extensive investigation. For example, 
are the host immune signaling mechanisms different in response 
to diverse Trypanosoma species and its components? How are 
complex signaling molecules and their interactions involved in 
either resistance or susceptibility of the host postinfection? What 
parasite antigens are recognized by TLR2, leading to activation 
of the innate immune system and immunity to T. congolense 
infection? Providing answers to these questions may pave the 
way for identification of novel targets that regulate intracellular 
events and pathways, leading to resistance and/or susceptibility 
to African trypanosomiasis.
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